Adverse emotional and interpersonal effects reported by 1829 New Zealanders while taking antidepressants

Psychiatry Research

Volumn 216, Issue 1, 2014, Pages 67-73

  Read, John ^a   Cartwright, Claire ^b   Gibson, Kerry ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Adverse effects; Antidepressants; Depression

Indexed keywords

ANTIDEPRESSANT AGENT;

ADDICTION; ADULT; AGE; ARTICLE; BEHAVIOR DISORDER; BODY WEIGHT DISORDER; DEPRESSION; DIARRHEA; DISEASE ASSOCIATION; DISEASE SEVERITY; DIZZINESS; DROWSINESS; EDUCATIONAL STATUS; EMOTIONAL DISORDER; FEMALE; HEADACHE; HEALTH BELIEF; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEW ZEALAND; ONLINE SYSTEM; ORGASM DISORDER; PERSONAL EXPERIENCE; PERSONALITY DISORDER; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; RESTLESSNESS; SEXUAL DYSFUNCTION; SUICIDAL BEHAVIOR; TREATMENT DURATION; TREMOR; WITHDRAWAL SYNDROME; XEROSTOMIA; ADOLESCENT; AGED; ATTITUDE TO HEALTH; CHEMICALLY INDUCED; DRUG EFFECTS; EMOTION; HEALTH CARE SURVEY; HUMAN RELATION; MIDDLE AGED; PSYCHOSEXUAL DISORDER; SELF REPORT; SUICIDAL IDEATION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; ATTITUDE TO HEALTH; DEPRESSION; EMOTIONS; FEMALE; HEALTH CARE SURVEYS; HUMANS; INTERPERSONAL RELATIONS; MALE; MIDDLE AGED; NEW ZEALAND; QUESTIONNAIRES; SELF REPORT; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL; SUICIDAL IDEATION; YOUNG ADULT;

EID: 84895899510     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2014.01.042     Document Type: Article

References (36)

1. Adkins D., Clark S., Åberg K., Hettema J., Bukszar J., McClay J., Souza R., van den Oord E. Genome-wide pharmacogenomic study of citalopram-induced side effects in STAR*D. Translational Psychiatry 2012, 10.1038/tp.2012.57PMCID:PMC3410623, July 3;2:e129.
2. Backenstrass M., Joest K., Frank A., Hingmann S., Mundt C., Kronmuller K. Preferences for treatment in primary care: a comparison of nondepressive, subsyndromal and major depressive patients. General Hospital Psychiatry 2006, 28:178-180.
3. Belaise C., Gatti A., Chouinard V., Chouinard G. Patient online report of selective serotonin reuptake inhibitor-induced persistent postwithdrawal anxiety and mood disorders. Psychotherapy and Psychosomatics 2012, 81:386-388.
4. Bogner H., Cahill E., Frauenhoffer C., Barg F. Older primary care patient views regarding antidepressants: a mixed methods approach. Journal of Mental Health 2009, 18:57-64.
5. Byng R., Bury C., Weaver L. Patients' experiences of consultations for depression and predictors of adherence to antidepressants. Primary Care and Community Psychiatry 2007, 12:109-115.
6. Dobson K., Hollon S., Dimidjian S., Schmaling K., Kohlenberg R., Gallop R., Rizvi S., Gollan J., Dunner D., Jacobson N. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the prevention of relapse and recurrence in major depression. Journal of Consulting and Clinical Psychology 2008, 76:468-477.
7. Education Counts, 2006. http://www.educationcounts.govt.nz/data/assets/excel_doc/0007/17836/Education_attainment%20of_the_population.xls.
8. Eli Lilly, 2012. Highlights of Prescribing Information: Prozac. http://pi.lilly.com/us/prozac.pdf.
9. Gibson, K., Cartwright, C., Read, J. (2014). Patient-centred perspectives on antidepressant use: a narrative review. International Journal of Mental Health Nursing 43, 1-14.
10. Givens J., Datto C., Ruckdeschel K., Knott K., Zubritsky C., Oslin D., Nyshadham S., Vanguri P., Barg F. Older patients[U+05F3] aversion to antidepressants. Journal of General Internal Medicine 2006, 21:146-151.
11. Goldberg L., Moncrieff J. The psychoactive effects of antidepressants and their association with suicidality. Current Drug Safety 2011, 6:1-7.
12. Hammad T., Laughren T., Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Archives of General Psychiatry 2006, 63:332-339.
13. Himei A., Okamura T. Discontinuation syndrome associated with paroxetine in depressed patients: a retrospective analysis of factors involved in the occurrence of the syndrome. CNS Drugs 2006, 20:665-672.
14. Honcamp E., Stevens A., Haffmans J. Patients[U+05F3] attitudes toward antidepressants. Psychiatric Services 2002, 53:1180-1181.
15. Ilyas S., Moncrieff J. Trends in prescriptions and costs of drugs for mental disorders in England, 1998-2010. British Journal of Psychiatry 2012, 200:393-398.
16. Kessing L., Hansen H., Demyttenaere K., Bech P. Depressive and bipolar disorders: patients[U+05F3] attitudes and beliefs towards depression and antidepressants. Psychological Medicine 2005, 35:1205-1213.
17. Kirsch I., Deacon B., Huedo-Medina T., Scoboria A., Moore T., Johnson B. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLOS Medicine 2008, 5:260-268.
18. Liebert R., Gavey N. 'I Didn[U+05F3]t Just Cross a Line I Tripped Over an Edge': experiences of serious adverse effects with selective serotonin reuptake inhibitors. New Zeland Journal of Psychology 2008, 37:38-48.
19. Lowe B., Schul U., Grafe K., Wilke S. Medical patients[U+05F3] attitudes toward emotional problems and their treatment. Journal of General Internal Medicine 2006, 21:39-45.
20. Makri G., Reutfors J., Ösby U., Isacsson G., Frangakis C., Ekbom A., Papadopoulos F. Suicide seasonality and antidepressants: a register-based study in Sweden. Acta Psychiatrics Scandinavica 2013, 127:117-125.
21. MIND, 2012. http://www.mind.org.uk/news/7546_antidepressants_prescribed_too_quickly_for_too_long_finds_mind_survey.
22. Moret C., Isaac M., Briley M. Problems associated with long-term treatment with selective serotonin reuptake inhibitors. Journal of Psychopharmacology 2009, 23:967-974.
23. Nassir G., Vohringer P., Whitham E. Antidepressants from a public health perspective: re-examining effectiveness, suicide, and carcinogenicity. Acta Psychiatrica Scandinavica 2013, 127:89-93.
24. Olfson M., Marcus S. National patterns in antidepressant medication treatment. Archives of General Psychiatry 2009, 66:848-856.
25. Perroud N., Uher R., Ng M., Guipponi M., Hauser J., Henigsberg N., Maier W., Mors O., Gennarelli M., Rietschel M., Souery D., Dernovsek M., Stamp A., Lathrop M., Farmer A., Breen G., Aitchison K., Lewis C., Craig I., McGuffin P. Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project. Pharmacogenomics Journal 2012, 12:68-77.
26. Pestello F., Davis-Berman J. Taking anti-depressant medication: a qualitative examination of internet postings. Journal of Mental Health 2008, 17:349-360.
27. Pigott H., Leventhal A., Alter G., Bowen J. Effficacy and effectiveness of antidepressants: current status of research. Psychotherapy and Psychosomatics 2010, 79:267-279.
28. Price J., Cole V., Goodwin G. Emotional side-effects of selective serotonin reuptake inhibitors: qualitative study. British Journal of Psychiatry 2009, 195:211-217.
29. Sirey J., Bruce M., Alexopoulos G., Perlick D., Friedman S., Meyers B. Stigma as a barrier to recovery: perceived stigma and patient-rated severity of illness as predictors of antidepressant drug adherence. Psychiatric Services 2001, 52:1615-1620.
30. Schofield P., Crosland A., Waheed W., Waquas A., Aseem S., Gask L., Wallace A., Dickens A., Tylee A. Patients[U+05F3] views of antidepressants: from first experiences to becoming expert. British Journal of General Practice 2011, 61:e142-e148.
31. Statistics New Zealand Household Use of Information and Communication Technology-2012 2013, Statistics New Zealand, Wellington, (accessed 22.04.13).
32. Statistics New Zealand, 2012. New Zealand in Profile 2012. http://www.stats.govt.nz.
33. Stone J., Durrance D., Wojcik W., Carson A., Sharpe M. What do medical outpatients attending a neurology clinic think about antidepressants?. Journal of Psychosomatic Research 2004, 56:293-295.
34. Uher R., Farmer A., Henigsberg N., Rietschel M., Mors O., Maier W., Kozel D., Hauser J., Souery D., Placentino A., Strohmaier J., Perroud N., Zobel A., Rajewska-Rager A., Dernovsek M., Larsen E., Kalember P., Giovannini C., Barreto M., McGuffin P., Aitchison K. Adverse reactions to antidepressants. British Journal of Psychiatry 2009, 195:202-210.
35. Van Geffen E., Gardarsdottir H., van Hulten R., van Duk L., Egberts A., Heerdink E. Initiation of antidepressant therapy: do patients follow the GP's prescription?. British Journal of General Practice 2009, 59:81-87.
36. Williams V., Baldwin D., Hogue S., Fehne S., Hollis K., Edin H. Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in 2 European countries: a cross-sectional patient survey. Journal of Clinical Psychiatry 2006, 67:204-210.